C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
about
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cellsFrom C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionC-reactive protein and coronary heart disease: all said--is not it?C-reactive protein in human atherogenesis: facts and fictionFcγ receptors and ligands and cardiovascular diseaseEndothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumPentraxins: structure, function, and role in inflammationContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.Discordant association of C-reactive protein with clinical events and coronary luminal narrowing in postmenopausal women: data from the Women's Angiographic Vitamin and Estrogen (WAVE) study.Microarray gene profiling of laser-captured cells: a new tool to study atherosclerosis in mice.Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRPPredictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populations.C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells.Effects of antisense oligonucleotides against C-reactive protein on the development of atherosclerosis in WHHL rabbits.Animal models of C-reactive protein.Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004).Neointimal formation is reduced after arterial injury in human crp transgenic miceMutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk.C-reactive protein-mediated vascular injury requires complement.Vitamin C treatment reduces elevated C-reactive proteinHuman C-reactive protein does not promote atherosclerosis in transgenic rabbits.Animal models of ischemic stroke. Part one: modeling risk factors.The association between subclinical atherosclerosis and uterine fibroids.Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice.Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agentsAgonistic antibody to angiotensin II type 1 receptor accelerates atherosclerosis in ApoE-/- mice.Endothelial cells, fibroblasts and vasculitisApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects.Atherosclerosis-related functions of C-reactive protein.C-reactive protein and atherogenesis: new insights from established animal models.Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.Systemic inflammation and early atheroma formation: are they related?Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis.Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins
P2860
Q24321501-8D991F53-62A7-4E76-B795-4EA07AB2BB6FQ26770209-7F93998B-F093-493E-81C8-E6396BBB7404Q26860959-C61E32A5-382F-462A-9A77-CA5EEF788536Q27013635-406C3539-135C-47F9-B0C3-25EFD046A099Q27021449-0BF565C7-0D1B-4B81-B415-677424C024CCQ28219326-65616533-FEF3-4ED0-95EA-276D5B8F7038Q28676262-630C29E5-AF55-4700-B32A-F0EDCB9E488FQ30318502-A5118B95-AEBC-44AD-B008-01C32D6B3FBBQ30319434-BC1FC0F6-BA46-4AF3-A81C-F00DFEE5410CQ30475959-D22DE756-5F7F-4404-B40D-E59D409FFE3DQ30645084-619494A8-F013-490D-B658-6D8B6D95F4BEQ33320713-7FDCA9BF-C8A6-4A63-B32F-C4C322F3A6B4Q33412124-BB77936D-958F-4C8E-AB36-6C21FCA6ACBEQ33448450-27127ECF-2122-44AF-941A-775EA6D6A577Q33456200-7FFB1ACD-5AB7-40FD-B6E7-4AEB0D35515AQ33562207-E86A2180-A5D3-413F-B676-40DE7C349BABQ33607457-A32FE073-A4E2-461F-9AF4-15A9EF7D19EEQ33607563-1B2670A6-7985-4F47-A1FD-6027D0A6B07AQ33743706-E15A136A-197A-4672-B2C0-DC3844DCDB1CQ33764038-79A7A18B-20C4-4167-90B9-6A5F992B6E2CQ33802547-54ADB939-7278-490F-BE01-646D78BB0AFFQ33905741-C0F6DC53-0B7D-4761-BEC1-B7ADECCDEBD4Q33961757-7B0A7724-01BE-42DA-8C41-D5A3322DAFD0Q34014359-A8E2ED4E-72B5-47B5-B0CF-ADE60E29B4C8Q34021492-86FF751D-5C40-48C1-8D07-CFEC4B7A4E21Q34086707-D0914746-3C6A-435D-B2CA-659E526C1CC0Q34603011-928F5F51-FD88-4FFC-8E84-BA0F0FA4385AQ34612908-DDC06355-FEE5-4437-99C2-EF9448B6BD40Q34675880-40168522-2FA9-4D35-A91B-DEF8A63CB9EEQ34901492-BEA28928-D762-4660-88B2-2E4531954966Q34978758-408F4FCA-50B6-4640-8A0D-44CDAB9DD21EQ35058025-E6AFCF52-D8FE-45C2-8989-E0CB8DEC4926Q35070590-472193CB-88ED-4E26-BEAC-57D5FDB13747Q35073552-B64866F5-2399-4529-9225-8DA29626295AQ35085254-61BA1E95-A50F-4EF2-89EE-44F1C4DDD658Q35106161-E6BCA924-EB72-41A7-B52E-4D8E50CDFDA9Q35154761-5894D19F-4CF1-4397-96FB-B5E07D49556DQ35555981-BB35B173-6A81-4D8A-A3B9-89B1E38FADBDQ35581624-5C38F199-AF14-4617-AD93-D15F1BB5F448Q35771582-F2A3105D-9613-4859-8D9F-4C50B7732D09
P2860
C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
C-reactive protein accelerates ...... olipoprotein E-deficient mice.
@en
C-reactive protein accelerates ...... olipoprotein E-deficient mice.
@nl
type
label
C-reactive protein accelerates ...... olipoprotein E-deficient mice.
@en
C-reactive protein accelerates ...... olipoprotein E-deficient mice.
@nl
prefLabel
C-reactive protein accelerates ...... olipoprotein E-deficient mice.
@en
C-reactive protein accelerates ...... olipoprotein E-deficient mice.
@nl
P2093
P1433
P1476
C-reactive protein accelerates ...... polipoprotein E-deficient mice
@en
P2093
Antoni Paul
Kerry W S Ko
Lawrence Chan
Mark A McCrory
Vijay Yechoor
P304
P356
10.1161/01.CIR.0000114526.50618.24
P407
P577
2004-01-26T00:00:00Z